Here we demonstrate, for the first time, that the central oncogenic c-MYC signaling pathway, previously shown to have important roles in HCC, is directly activated by IRE1α signaling via XBP1s in sorafenib-resistant cells. This evidence concerns the gene ERN1 and hepatocellular carcinoma.